Retaining Analysts Views in Focus: Novartis (NYSE:NVS), ACADIA Pharmaceuticals (NASDAQ:ACAD)

Novartis AG (NYSE:NVS) [Trend Analysis], stock dropped around -0.68% in early session as its gaining volume of 5.32 Million. Finally, analysts shed their light over the NVS price targets; maintaining price high target of 92.00 while at average the price target was 80.43 in contrast with the current price of 73.42. The price targets are usually acts as the boosters or blasters in the performance of stock. A higher price target would definitely provide confidence to investors during the trading action, consideration given by Wall Street Journal.

So does the rankings given by analysts; let us highlight rankings table and we had 11 analyst recommending BUY ratings for current month and for previous month 12 stands on similar situation; while 17 for the current month as compared to 14 analysts recommending for HOLD from the pool for previous month. While 2 stands at overweight and 1 out of pool consider it as Sell for current month. For the overall, consensus ratings were for Overweight.

The stock showed weekly upbeat performance of 1.75%, which maintained for the month at 0.80%. Similarly, the positive performance for the quarter recorded as 3.38% and for the year was 0.59%, while the YTD performance remained at 0.80%. NVS has Average True Range for 14 days of 0.99.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) [Trend Analysis] pretends to be active mover, stock dropped around -0.29% to traded at $34.49. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked ACAD in recent few months. In ratings table the ACAD given BUY ratings by 7 analysts in current phase and 1 analyst suggest it as overweight security. None of analyst/s has SELL recommendation for current month on ACAD. While 3 number of analysts gave ratings for HOLD in current as compared to 1 analyst giving UNDERWEIGHT. As per remarks given by WSJ, overall consensus pool recommends it as Overweight security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $-0.66 at current month while compared with $-0.66 in a month ago. The stock next year first quarter current estimate trend for EPS was for $-0.62 and on annual basis FY 2016 estimate trends at current was for $-2.35 as compared to one month ago of $-2.35, and for next year per share earnings estimates have $-2.25.

The liquidity measure in recent quarter results of the company was recorded 15.40 as current ratio, on the other side the debt to equity ratio was 0.00, and long-term debt to equity ratio remained 0.01. The Company has gross margin of 74.50%. (Read Latest [Free Analytic] Facts on NASDAQ:ACAD and Be Updated)

For latest Market Updates Subscribes Here

 

About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *